Statistics
Publications
9
Citations
392
H-Index
9
Active since
2017
Peizhi Lu is an author at Sun Yat-sen University specializing in medicine, oncology, and cancer pharmacology.
Publications per year
2017–2024
9
9
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Feng Ji, Peizhi Lu, Guangzhi Zhu et al. · Acta Pharmacologica Sinica · 2020 · 165 citations · Full text
Medicine, Cancer Biology, Oncology +16
Wenjing Su, Peizhi Lu, Yong Wu et al. · Frontiers in Oncology · 2021 · 60 citations · Full text
Medicine, Oncology, Pharmacology +17
A pilot clinical study of apatinib plus irinotecan in patients with recurrent high-grade glioma
Lei Wang, Lijun Liang, Tao Yang et al. · Medicine · 2017 · 48 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 9